ARNI seems to give CV benefit up to EF of about 60%, not only in HFrEF
This recording was independently developed under auspices of EPCCS. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of EPCCS.
Scott David Solomon is Director Noninvasive Cardiology, Cardiovascular Medicine, Brigham and Women's Hospital and Professor at Harvard Medical School, Boston, MA, USA.
This video was recorded at the congress of the American Heart Association in Philadelphia, on November 16-18, 2019.
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.
Share this page with your colleagues and friends: